Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Biogen (NASDAQ: BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) Grows Presence in China with the Approval of TECFIDERA for Treatment of Relapsing Multiple Sclerosis
- New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis
- 'A Pump and Dump SPAC Scam': Quantumscape (QS), Backed by Bill Gates and Volkswagen, Falls 10% On a Short Report from Scorpion Capital
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
